Ewa Wandzioch

Title: Ewa Wandzioch: Innovator in Cancer Diagnostics

Introduction

Ewa Wandzioch is a prominent inventor based in Wyndmoor, PA (US). She has made significant contributions to the field of medical diagnostics, particularly in the area of cancer research. With a total of 2 patents, her work focuses on innovative methods to predict and diagnose endometrial cancer.

Latest Patents

Wandzioch's latest patents include the use of PME-1 as a biomarker to predict and diagnose an increased risk of endometrial cancer. Additionally, she has developed gene silencing techniques for PME-1 to inhibit epithelial to mesenchymal transition. These methods involve the use of siRNAs or shRNAs to target PME-1, effectively reducing its mRNA levels. The research demonstrates that these targeted approaches can attenuate the epithelial to mesenchymal transition, thereby inhibiting the development of endometrial cancer. Furthermore, she has disclosed a kit containing siRNA or shRNA reagents designed to attenuate PME-1 gene expression.

Career Highlights

Ewa Wandzioch is currently associated with Medical Diagnostic Laboratories, LLC, where she continues to advance her research in cancer diagnostics. Her innovative work has the potential to significantly impact the early detection and treatment of endometrial cancer.

Collaborations

Wandzioch collaborates with notable colleagues, including Lyndi Rice and Michelle Pusey, who contribute to her research endeavors.

Conclusion

Ewa Wandzioch's contributions to cancer diagnostics through her innovative patents and research are paving the way for improved methods of predicting and diagnosing endometrial cancer. Her work exemplifies the importance of innovation in the medical field.